Search 

Felicitex Therapeutics is a drug discovery company at the forefront of one of the most promising areas in oncology –quiescent (sleeping) cancer cells. We are developing treatments and diagnostic assays to improve the effectiveness and long-term outcomes of treatments for the deadliest and most therapy resistant cancers: pancreatic, colorectal, non-small cell lung, and ovarian.

Recently, it has become accepted in the scientific community that populations of malignant cells are not homogenous, they have hierarchy.  Some of the cancer cells divide rapidly but some do not, some of the cancer cells are sleeping. They are in the quiescent state. This is especially true of solid tumors in which the cells in the outer layers are proliferating, but the inner volume comprises a large proportion of quiescent cells, frequently as a result of inadequate nutrient supply and oxygen deprivation (hypoxia). Hypoxic regions have long been known to be resistant to chemotherapy and radiation treatment. Tumor hypoxia, as a target for chemotherapy, is currently an active area of research.

Moreover, when cancer cells are under stress from either chemotherapy, anti-angiogenesis therapy, specific targeted treatment, or radiation, cancer cells often go to “sleep”, or use quiescent as a niche to hide.  After the completion of treatment, these cells can acquire resistance to the current treatment, begin growing and cause cancer recurrence. This process is called pharmacological quiescence.

Fox Rothschild LLP is a national law firm with more than 600 attorneys practicing in 21 offices coast to coast. We’ve been serving clients for more than a century, and we’ve been climbing the ranks of the nation’s largest firms for many years, according to both The Am Law 100 and The National Law Journal. 

Our lawyers provide a full range of legal services to public and private companies – from family-run businesses to multinational corporations. We also represent charitable, medical and educational institutions both in the United States and in more than 50 countries worldwide.

We’re smart. We’re solid. We’re established. But we believe we’re also a bit different from many other law firms — and we’re proud of it.

We’re entrepreneurial. We’re resourceful. We’re nimble. It’s those qualities that clients tell us they value in their lawyers — and that have allowed us to build a firm of bright, creative, responsive attorneys with solid legal know-how and valuable industry experience.

Our lawyers partner with clients and work hand-in-hand with them to keep pace with their business objectives and anticipate the challenges ahead. Our entrepreneurial approach — as a firm that works in the trenches with clients, helping them to achieve their goals — is a characteristic that differentiates us. When you choose Fox, you gain an advisor that will be as dedicated to your success as you are.

French BioBeach is a Life Science Catalyst between France & Southern California, Enabling and Fostering Business Relationships. We work with SoCal companies on their European Expansion and with French companies on their US expansion. We facilitate Partnering Opportunities and/or Physical Implantation (incubator).

WHO WE ARE The French-American Biotechnology Springboard (FABS) is a steering committee developed in collaboration with the French-American Chamber of Commerce of New England [FACCNE] to guide French Bio-Entrepreneurs in the highly specific scientific, business and cultural New England environment. The Group is comprised of American and French professional volunteers with complementary backgrounds and competencies, who have had and/or are currently holding positions in Massachusetts-based Biotechnology and Pharmaceutical Companies.   WHAT WE DO -Mentoring French companies that are evaluating or have decided to start their business in the New England. -Guiding the French Bio-Entrepreneurs first installation steps, sharing their experience and expertise and facilitates their development by leveraging the local expertise of a dynamic network of professionals. -Supporting FACCNE life sciences activities with a yearly FACCNE Biotech meeting in March. -Coaching start ups/Institutions to better prepared to the US market during French biotech tours (presentations, one on one coaching). -Helping US Companies to explore / connect with French market through participation to programs such as the Boston based Office for Science and Technology - accelerator designed to help entrepreneurs grow their business in France and Europe.

Fosters, develops and commercializes healthcare and life sciences technology.

Our team’s decades of experience and vast professional network can turn your company’s goals into reality. GAP Ventures provides “hands-on” support to facilitate the acquisition of investors, strategic partners and key customers in the U.S. and Canada.

We look for the strong fundamentals, good science and innovative technology, and work with  entrepreneurs and executive management to:

• Identify U.S. market objectives and strategy with clear, value-creating milestones
• Establish U.S. business registration and operations
• Increase your network of contacts in the industry: pharma, medical device, diagnostics or health IT
• Increase your network of investor contacts: angels, venture capital, investment bankers, and strategic partners.

GAP Ventures provides “on the ground’ resources to expand your business contacts and access key North American markets.

GCA Therapeutics Ltd (GCAT) is a US based, specialty pharmaceutical company focusing on in-licensing, acquisition and marketing of mid through late stage drug candidates and technologies from North America and the EU. GCAT applies its expertise and resources in pre-clinical, clinical, and final regulatory review and approval phases to commercialize products for use in the Chinese market. GCAT is currently in discussion with several US and European biotech and pharma firms to bring several important drugs to market through its joint venture in Tianjin, China. Initially, GCAT will market its products through a 3rd party distribution/sales partnership and will construct or acquire manufacture capabilities in China at a later date. GCAT currently has operations in New Jersey, New York, Shanghai, and Beijing.

GeneDx specializes in genetic testing for rare hereditary disorders. Our mission is to make clinical testing available to people with rare genetic conditions and their families. Most of our tests include full gene analysis by DNA sequencing, the gold standard of genetic testing. We invite you to explore our site, where you will find comprehensive information and all of our paperwork. Please note that GeneDx does not provide Direct-to-Consumer testing. All tests must be ordered, and results sent to a health care provider, usually a physician or genetic counselor. Families are encouraged to present our material to their health care providers who can evaluate the appropriateness of testing. For diagnostic testing in rare disorders, contact GeneDx… Where rare is common.

GENEWIZ is a leading global genomics service company. A full-service provider, GENEWIZ provides DNA sequencing, gene synthesis, molecular biology, next generation sequencing, bioinformatics, and GLP regulatory and clinical services. 

From the company’s founding, GENEWIZ has maintained its unwavering commitment to providing customers with the best value. Excelling in both science and customer support, GENEWIZ is dedicated to accelerating scientific discovery, as well as to developing and delivering innovative solutions for translational medicine and healthcare. Easily accessible around the world, GENEWIZ is the preferred partner at leading academic, pharmaceutical, biotechnology, agricultural, government, and clinical institutions. 

At GENEWIZ, it is our mission to contribute to the advancement of life sciences and technologies. Together with our clients, we can make a difference in the pursuit of scientific discoveries, better healthcare, a greener environment, and abundant food supplies. Our goal is to be the best in the world and the best for the world. 

Headquartered in South Plainfield, NJ, GENEWIZ is a privately-held global enterprise with locations in Boston, MA; Washington, DC Metro; Research Triangle Park, NC; San Diego, CA; San Francisco, CA; and Seattle, WA. International locations include Beijing, China; Suzhou, China; London, United Kingdom; Langen, Germany; and Tokyo, Japan.

DNA Sequencing; Gene Synthesis; Mutation Analysis; SNP Discovery; Sequencing from Bacteria and Phage; Difficult Template Sequencing; Plasmid Preparation; Site-directed Mutagenesis; Fragment Analysis